21 – 30 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and App NL−F/NL−F mice
(
- Contribution to journal › Article
-
Mark
Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies : An up to 10-year follow-up study
(
- Contribution to journal › Article
-
Mark
The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer’s Disease Pathology
(
- Contribution to journal › Article
- 2023
-
Mark
Rates of Progression in Patients with Alzheimer’s Disease Depending on Apolipoprotein E Genotype and Concomitant Medications.
2023) 16th Clinical Trials on Alzheimer's Disease Conference(
- Contribution to conference › Poster
-
Mark
Diabetic Neuropathy assessed with Multifrequency Vibrometry Develops Earlier than Nephropathy but Later than Retinopathy
(
- Contribution to journal › Article
-
Mark
Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide
(
- Contribution to journal › Article
-
Mark
Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Does fatigue in Parkinson’s disease impact one’s physical function in daily live?
2023) The 2023 Inational Congress of Parkinson’s Disease and Movement Disorderst(
In Movement Disorders 38(Suppl 1). p.824-824- Contribution to journal › Published meeting abstract
-
Mark
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
(
- Contribution to journal › Article
-
Mark
Sex differences in disease progression in Alzheimer patients with different concomitant medications.
2023) 17th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2023)(
- Contribution to conference › Abstract